A carregar...
DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
A novel coronavirus disease, COVID-19, has emerged as a global public health issue. Clinical course of disease significantly correlates with the occurrence of some comorbidities, among them type 2 diabetes. According to recent structural studies the dipeptidyl peptidase 4, a key molecule in the path...
Na minha lista:
| Publicado no: | Arch Immunol Ther Exp (Warsz) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850901/ https://ncbi.nlm.nih.gov/pubmed/33527308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00005-020-00602-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|